Abstract
There is considerable evidence that disturbances in the mechanisms controlling circadian rhythms play an important part in the aetiology of depression (Hallonquist et al., 1986). For instance, Carrol et al. (1976) reported that 88% of bipolar and 50% of unipolar depressives demonstrated early escape from overnight dexamethasone suppression. Wehr et al. (1983) suggested that this phenomenon could be explained by a resetting of the ‘biological clock’. Thus if, as they observed, circadian rhythms of depressives are phase-advanced compared with control subjects, one might expect an early escape since the drug will have been given later in the circadian cycle of the depressives.
Preview
Unable to display preview. Download preview PDF.
References
Brazell, M.P., Marsden, C.A., Nisbet, A.P., and Routledge, C. (1985). The 5-HT receptor agonist RU 24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br. J. Pharmacol., 86, 209–18.
Carroll, B.J., Curtis, G.C, and Mendels, J. (1976). Arch. Gen. Psychiat., 33, 1039–48.
de Montigny, C., Blier, P., and Chaput, Y. (1984). Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropharmacology, 23, 1511–20.
Dompert, W.U., Glaser, T., and Traber, J. (1985). [3H]-TVX Q 7821: identification of 5-HT1 binding sites as a target for a novel putative anxiolytic. Naunyn-Schmiedeberg’s Arch. Pharmacol, 328, 467–70.
Doods, H.N., Kalkman, H.O., Dejonge, A., Thooler, M.J.M. C., Wilffert, B., Timmermans, P.B.M.W.M., and Vanzwieten, P. (1985). Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites, correlation between 5-HT1A affinity and hypotensive activity. Eur. J. Pharmacol., 112, 363–70.
Doxey, J.C., Roach, A.G., and Smith, C.F.C. (1983). Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors. Br. J. Pharmacol., 78, 489–505.
Ennis, C. (1986). The 5-HT autoreceptor in the rat hypothalamus resembles a 5-HT1B receptor. Br. J. Pharmacol., 88, 370P.
Faradji, H., Cespuglio, R., and Jouvet, M. (1983). Voltammetric measurements of 5-hyd-roxyindole compounds in the suprachiasmatic nucleus: circadian fluctuations. Brain Res., 279, 111–19.
Fozard, J.R., and McDermott, I. (1985). The cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat. Br. J. Pharmacol., 84, 69P.
Hallonquist, J.D., Goldberg, M.A., and Brandes, J.S. (1986). Affective disorders and circadian rhythms. Can. J. Psychiatry, 31, 259–72.
Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikstrom, H., Arvidssen, L.-E., Hacksell, U., and Nilsson, J.L.G. (1982). 8-Hydroxy-2-(di-n-propylamino) tetralin, (8-OH-DPAT) a potent and selective simplified argot congener with central 5-HT-receptor stimulating activity. J. Neural. Trans., 55, 169–88.
Marsden, C.A., and Martin, K.F. (1985a). RU 24969 decreases 5-HT release in the SCN by acting on 5-HT receptors in the SCN but not the dorsal raphe. Br. J. Pharmacol, 85, 219P.
Marsden, C.A., and Martin, K.F. (1985b). In vivo voltammetric evidence that the 5-HT autoreceptor is not of the 5-HT1A sub-type. Br. J. Pharmacol, 86, 445P.
Marsden, C.A., and Martin, K.F. (1986). Involvement of 5-HT1A and α2 receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Br. J. Pharmacol, 89, 277–86.
Martin, K.F., and Marsden, C.A. (1986a). In vivo voltammetry in the suprachiasmatic nucleus of the rat: Effects of RU 24969, methiothepin and ketanserin. Eur. J. Pharmacol., 121, 135–40.
Martin, K.F., and Marsden, C.A. (1986b). Pharmacological manipulation of the serotoner-gic input to the SCN–an insight into the control of circadian rhythms. Ann. N. Y. Acad. Sci., 473, 542–5.
Martin, K.F., Mason, R., and McDougall, H. (1986). Electrophysiological evidence that isapirone (TVX Q 7821) is a partial agonist at 5-HT1A receptors in the rat hippocampus. Br. J. Pharmacol, 89, 729P.
Middlemiss, D.N. (1984). 8-Hydroxy-2-(di-n-propylamino) tetraline is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H]-5-HT recognition site. Naunyn-Schmiedeberg’s Arch. Pharmacol, 327, 18–22.
Middlemiss, D.N. (1985). The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol, 37, 434–7.
Middlemiss, D.N., and Fozard, J.R. (1983). 8-Hydroxy-2-(di-n-propylamino) tetralin discriminates between subtypes of the 5-HT recognition site. Eur. J. Pharmacol, 90, 151–3.
Moore, R.Y. (1983). Organisation and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nuclei. Fed. Proc, 42, 2783–9.
Moret, C. (1985). Pharmacology of the serotonin autoreceptor. In Green, A.R. (ed.), Neuropharmacology of Serotonin. Oxford University Press, Oxford, 21–49.
Pedigo, N.W., Yamamura, H.J., and Nelson, D.L. (1981). Discrimination multiple [3H]-5 hydroxytryptamine binding by neuroleptic spiperone in rat brain. J. Neurochem., 36, 220–6.
Peroutka, S.J., and Snyder, S.H. (1979). Multiple serotonin receptors: Differential binding of [3H]-5 hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Mol. Pharmacol., 16, 687–99.
Schnellman, R.G., Waters, S.J., and Nelson, D.L. (1984). [3H]-5-Hydroxytryptamine binding sites: species and tissue variation. J. Neurochem., 42, 65–70.
Schuuman, T., Davies, M.A., Dompert, W.U., and Traber, J. (1984). TVX Q 7821: a new nonbenzodiazepine putative anxiolytic. 9th Int. Congr. Pharmacol, London, 1463.
Sills, M.A., Wolfe, B.B., and Frazer, A. (1984). Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J. Pharmacol. exp. Ther., 231, 480–7.
Wehr, T.A., Sack, D., Rosenthal, N., Duncan, W., and Gillin, J.C. (1983). Circadian rhythm disturbances in manic-depressive illness. Fed. Proc, 42, 2809–14.
Wirz-Justice, A., Groos, G.A., and Wehr, T.A. (1982). The neuropharmacology of circadian timekeeping in mammals. In Aschoff, J., Daan, S., and Groos, G.A. (eds.), Vertebrate Circadian Systems, Structure and Physiology, Springer, Berlin, 183–93.
Editor information
Editors and Affiliations
Copyright information
© 1988 The Editors and the Contributors
About this chapter
Cite this chapter
Martin, K.F., Marsden, C.A. (1988). In-vivo Identification of the Serotonin (5-HT) Autoreceptor in the Rat Suprachiasmatic Nucleus (SCN). In: Briley, M., Fillion, G. (eds) New Concepts in Depression. Palgrave, London. https://doi.org/10.1007/978-1-349-09506-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-349-09506-3_5
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09508-7
Online ISBN: 978-1-349-09506-3
eBook Packages: MedicineMedicine (R0)